ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Transgene Sa

Transgene Sa (0OCQ)

3.04
0.00
(0.00%)
Closed November 27 10:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
3.04
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
3.04 52 Week Range 3.04
Market Cap
Previous Close
3.04
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
5
Shares Outstanding
100,853,000
Dividend Yield
-
PE Ratio
-3.43
Earnings Per Share (EPS)
-0.22
Revenue
7.9M
Net Profit
-22.33M

About Transgene Sa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Illkirch-graffenstaden, Bas-rhin, Fra
Founded
-
Transgene Sa is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0OCQ. The last closing price for Transgene was 3.04 €. Over the last year, Transgene shares have traded in a share price range of 3.04 € to 3.04 €.

Transgene currently has 100,853,000 shares outstanding. The market capitalization of Transgene is 306.59 € million. Transgene has a price to earnings ratio (PE ratio) of -3.43.

0OCQ Latest News

Transgene fait le point sur ses activités, son portefeuille et sa situation financière au troisième trimestre 2024

Transgene fait le point sur ses activités, son portefeuille et sa situation financière au troisième trimestre 2024 TG4050 : Données prometteuses de Phase I présentées au SITC 2024 confirmant une...

Transgene Reports Business, Pipeline and Financial Update for Q3 2024

Transgene Reports Business, Pipeline and Financial Update for Q3 2024 TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck...

Transgene et NEC présentent de nouvelles données confirmant la preuve de principe clinique pour son vaccin thérapeutique TG4050, dans les cancers de la tête et du cou au SITC 2024

Transgene et NEC présentent de nouvelles données confirmant la preuve de principe clinique pour son vaccin thérapeutique TG4050, dans les cancers de la tête et du cou au SITC 2024 Les données de...

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024 Compelling 24.1-month median follow-up data...

Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés

Transgene et ProBioGen collaborent pour faire progresser le développement des vaccins thérapeutiques individualisés Strasbourg (France), Berlin (Germany), le 5 novembre 2024, 7 h 30 Transgene...

Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development

Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development Strasbourg (France), Berlin (Germany), November 5, 2024, 7:30 a.m. CET—Transgene (Euronext Paris: TNG), a...

Transgene fait le point sur l’étude de Phase II du vaccin thérapeutique TG4001 dans les cancers du col de l’utérus et anogénitaux HPV16 positifs, récurrents ou métastatiques

Transgene fait le point sur l’étude de Phase II du vaccin thérapeutique TG4001 dans les cancers du col de l’utérus et anogénitaux HPV16 positifs, récurrents ou métastatiques Les premiers résultats...

Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers

Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers Top line data show that the randomized...

Transgene présentera un poster sur les données actualisées de TG4050 au SITC 2024

Transgene présentera un poster sur les données actualisées de TG4050 au SITC 2024 Transgene présentera le suivi médian à 24 mois des patients del'essai de Phase I évaluant le vaccin thérapeutique...

Transgene to Present a Poster on Updated Data for TG4050 at SITC 2024

Transgene to Present a Poster on Updated Data for TG4050 at SITC 2024 Transgene will present median 24-month follow up data from patients enrolled in the Phase I trial evaluating the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1003.043.043.04453.04DE
4003.043.043.04113.04DE
12003.043.043.0453.04DE
26003.043.043.0473.04DE
52003.043.043.04333.04DE
156003.043.043.043253.04DE
260003.043.043.0410653.04DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 72.30
(0.00%)
0
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 72.30
(0.00%)
0
0R24Intel Corp
US$ 24.05
(0.00%)
8.09k
0R0XTesla Inc
US$ 338.30
(0.00%)
2.15k
0A6LGamestop Corp
US$ 30.8875
(0.00%)
1.97k
0A2SPdd Holdings Inc
US$ 134.00
(0.00%)
1.49k
0HCIAlibaba Group Holding Ltd
US$ 85.10
(0.00%)
1.22k

Discussion

View Full Feed
Truth_is_a_tool Truth_is_a_tool 6 minutes ago
“” quit spamming the board “
She thinks she’s accomplishing a profound feat with her googling 🤣🤣🤣.
KBLB
worthylion worthylion 13 minutes ago
FTCO Been sliding lately as gold has declined a little despite 9%+ dividend yield. IMO Trump's presidency likely to be inflationary and create market uncertainty. A market "risk on" reaction to his election could turn into "risk off" after inauguration and increase the risk of an overdue correction.
FTCO
Steady_T Steady_T 17 minutes ago
Maybe. I'd rather see them spend their efforts on getting the NDA finished.

Having said that, there are a number of trials that I'd like to see get underway with Parkinson's being one of them.
AVXL
newflow newflow 19 minutes ago
lota WMI as a creditor has any claims against R?. Who is representing WMI as a creditor to R?.
COOP
Maximilliano Maximilliano 20 minutes ago
Trump's announcement said the council "will consist of all Departments and Agencies involved in the permitting, production, generation, distribution, regulation, transportation, of ALL forms of American Energy."

https://www.axios.com/2024/11/26/trump-ai-czar-role-elon-musk
FCEL
Dodger1 Dodger1 22 minutes ago
yep, all good as long as you have people to drive a car to the office building.

You all will figure it out in the end. Money...? Right..? Being..?

Go $AABB
AABB
Buellersback Buellersback 24 minutes ago
You most certainly are. It's very obvious and kind of disgusting. You are the reason this chat turned into a sh## show and everyone here knows it. The rest of the clowns joined in once you started the 'I'm just here for cheap entertainment" parade.
RGLG
thistraderknowsall thistraderknowsall 25 minutes ago
ZENA wakeup call for the shorts! $20 to $50 is next target ! Enjoy your margin covering !!
longago longago 28 minutes ago
Their PR is abysmal that is for damn sure.

If Ron does not at least glance at the comments here he is not learning anything.

Next week after Thanksgiving and after Q1 has ended I am going to try to engage him in a reasonable email conversation about some of the issues
RJDG
Ricorich Ricorich 31 minutes ago
style="font-size: 1.5em"AgEagle Aerial Systems Invited to the White House for Key Discussions on Commercial Unmanned Aerial Vehicles (UAVs)

https://ageagle.com/ageagle-aerial-systems-invited-to-the-white-house-for-key-discussions-on-commercial-unm
UAVS
Wolf-man jack Wolf-man jack 32 minutes ago
WQLF SAYS ; CVSI is still plugging along with three AcQisitions and more to come before CVSI gets AcQuired YQU WILL Then Understand YQU Understand. Have Mercy Have Faith Have Patience Have International Partners and M&A’s WQLF Ahooooooo

Gimminy Cricket 🦗 Said;

CVSI
Guzzi62 Guzzi62 32 minutes ago
No EU but UK!!
AVXL
jog49 jog49 38 minutes ago
Why? Because "sources" said so. LOL! It's amazing that people will buy into this BS.
FNMA
dinogreeves dinogreeves 40 minutes ago
Genius thought by someone on ST thread. He is right, especially with these tariffs, interest rates could go up.

"Paying off loans early for several strategic and financial reasons:

Paying off loans early can save the company money by avoiding future interest payments,
SMCI
lodas lodas 41 minutes ago
Your posts asserts WMI's position that it will abandon the ownership of WAMU's stock, and all rights , and the EQUITY IN THE STOCK!!!!!!!!......yet, ron makes the assertion that WMI placed 20.7 billion dollars in a Treasury Bill drawing interest, and is now worth over 27 billion dollars!!!!!.... how
JPM
dinogreeves dinogreeves 52 minutes ago
Very sad how people got robbed on this, grant it, only 660,000 volume, but is fair to say 300,000 shares got robbed and now some people are going to take a tax loss before the year is up. I wonder who was behind this move, company or frontloaders? They hyped it because of the low float, wow, just
TGLO
skitahoe skitahoe 53 minutes ago
I know this article was posted here, but I'd like to do it again and recommend the moderators consider stickying the article.

https://www.barchart.com/story/news/29772004/cancer-vaccines-market-forecasted-to-surge-in-coming-years-20242034-analysis-by-delveinsight-dendreon-pharma-cande
NWBO
littlejohn littlejohn 55 minutes ago
Canada got their pipeline to west coast completed

and is shipping more oil overseas

from there in 2024...

They may not want to get dragged thru

more Keystone flip flops...

More rich going to D.C. don't care about
skitahoe skitahoe 58 minutes ago
The question in my mind is how long can they go without communicating with shareholders, and not be in trouble with the authorities. I know the OTC and Pinks are the Wild West of stock investment, and I have seen companies rise from the dead after years of not reporting, but I believe it cost them
CRTG
dinogreeves dinogreeves 58 minutes ago
They know they are financially a strong company, they know they are massively cash flow positive, more importantly, they know their business model is largely scalable, why else would they pay off their loans. Let's get the facts straight, this is not share selling scheme, this company is fundamenta
SMCI
lovethatgreen lovethatgreen 60 minutes ago
Up another billion wow

This is a waste of time
RDAR
dinogreeves dinogreeves 1 hour ago
Late in the move, suggesting with the filings, SMCI is going make Hindenburg go bankrupt for trying to run their name through the mud. Big time redemption. Watch for press release tomorrow for the reason to payoff the notes is for financial flexibility. The only thing I want to know, how much mor
SMCI
XenaLives XenaLives 1 hour ago
B.S. and malfeasance liike this is the simplest expolanation for the heath crisis in this country.

$$$$ are much more important than quality of life or life expectancy of patients....

https://www.biospace.com/drug-development/mercks-former-asthma-blockbuster-singula

Your Recent History

Delayed Upgrade Clock